DWC202313

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DWC202313, covering 2025-12-05 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension [Phase 3]

See pricing